Nuclear variants of bone morphogenetic proteins

BMC Cell Biology

Volumn 11, Issue 1, 2010, Pages

  Felin, Jenny E ^a   Mayo, Jaime L ^a   Loos, Trina J ^a   Jensen, J Daniel ^a   Sperry, Daniel K ^a   Gaufin, Stephanie L ^a   Meinhart, Christopher A ^a   Moss, Jennie B ^a   Bridgewater, Laura C ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GROWTH DIFFERENTIATION FACTOR 5; SIGNAL PEPTIDE; GDF5 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; START CODON; AMINO ACID SEQUENCE; ANIMAL; CELL DIVISION; CELL LINE; CELL NUCLEUS; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CELL DIVISION; CELL LINE; CELL NUCLEUS; CODON, INITIATOR; GROWTH DIFFERENTIATION FACTOR 5; MICE; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION;

EID: 77949443468     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-20     Document Type: Article

References (47)

1. Urist MR: Bone: formation by autoinduction. Science 1965, 150:893-899.
2. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
3. Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
4. Mishina Y: Function of bone morphogenetic protein signaling during mouse development. Front Biosci 2003, 8:d855-869.
5. Hogan BL: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
6. Schlange T, Arnold HH, Brand T: BMP2 is a positive regulator of Nodal signaling during left-right axis formation in the chicken embryo. Development 2002, 129:3421-3429.
7. Kawamura C, Kizaki M, Ikeda Y: Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells. Leuk Lymphoma 2002, 43:635-639.
8. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992, 32:160-167.
9. Raida M, Clement JH, Ameri K, Han C, Leek RD, Harris AL: Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Int J Oncol 2005, 26:1465-1470.
10. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T, Kitajima I: BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 2005, 23:411-419.
11. Zhang H, Bradley A: Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
12. Goldstein AM, Brewer KC, Doyle AM, Nagy N, Roberts DJ: BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system. Mech Dev 2005, 122:821-833.
13. Kanzler B, Foreman RK, Labosky PA, Mallo M: BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development 2000, 127:1095-1104.
14. Langenfeld EM, Langenfeld J: Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004, 2:141-149.
15. Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL: Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 2005, 131:741-750.
16. Mishina Y: Function of bone morphogenetic protein signaling during mouse development. Front Biosci 2003, 8:855-869.
17. Chen D, Zhao M, Harris SE, Mi Z: Signal transduction and biological functions of bone morphogenetic proteins. Front Biosci 2004, 9:349-358.
18. Constam DB, Robertson EJ: Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 1999, 144:139-149.
19. Wozney JM: Bone morphogenetic proteins. Prog Growth Factor Res 1989, 1:267-280.
20. Celil AB, Hollinger JO, Campbell PG: Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 2005, 95:518-528.
21. Lemonnier J, Ghayor C, Guicheux J, Caverzasio J: Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. J Biol Chem 2004, 279:259-264.
22. Moustakas A, Heldin CH: From mono-to oligo-Smads: the heart of the matter in TGF-beta signal transduction. Genes Dev 2002, 16:1867-1871.
23. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S: Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 2001, 28:491-498.
24. Adam SA: The nuclear pore complex. Genome Biol 2001, 2:REVIEWS0007.
25. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY: Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 1995, 20:448-455.
26. George TC, Fanning SL, Fitzgerald-Bocarsly P, Medeiros RB, Highfill S, Shimizu Y, Hall BE, Frost K, Basiji D, Ortyn WE, Morrissey PJ, Lynch DH: Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Methods 2006, 311:117-129.
27. Cui Y, Jean F, Thomas G, Christian JL: BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. Embo J 1998, 17:4735-4743.
28. Granjeiro JM, Oliveira RC, Bustos-Valenzuela JC, Sogayar MC, Taga R: Bone morphogenetic proteins: from structure to clinical use. Braz J Med Biol Res 2005, 38:1463-1473.
29. Thomas G: Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 2002, 3:753-766.
30. Anderson ED, Thomas L, Hayflick JS, Thomas G: Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J Biol Chem 1993, 268:24887-24891.
31. Watanabe M, Hirano A, Stenglein S, Nelson J, Thomas G, Wong TC: Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J Virol 1995, 69:3206-3210.
32. Jean F, Stella K, Thomas L, Liu G, Xiang Y, Reason AJ, Thomas G: alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc Natl Acad Sci USA 1998, 95:7293-7298.
33. Nakayama K: Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 1997, 327(Pt 3):625-635.
34. Kozak M: Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 1991, 266:19867-19870.
35. Wang EA, Rosen V, DAlessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, et al: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990, 87:2220-2224.
36. Jans DA, Hassan G: Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling? Bioessays 1998, 20:400-411.
37. Johnson HM, Subramaniam PS, Olsnes S, Jans DA: Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 2004, 26:993-1004.
38. Nguyen M, He B, Karaplis A: Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology 2001, 142:694-703.
39. Lam MH, Hu W, Xiao CY, Gillespie MT, Jans DA: Molecular dissection of the importin beta1-recognized nuclear targeting signal of parathyroid hormone-related protein. Biochem Biophys Res Commun 2001, 282:629-634.
40. Bugler B, Amalric F, Prats H: Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 1991, 11:573-577.
41. Antoine M, Reimers K, Dickson C, Kiefer P: Fibroblast growth factor 3, a protein with dual subcellular localization, is targeted to the nucleus and nucleolus by the concerted action of two nuclear localization signals and a nucleolar retention signal. J Biol Chem 1997, 272:29475-29481.
42. Kiefer P, Acland P, Pappin D, Peters G, Dickson C: Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. Embo J 1994, 13:4126-4136.
43. Henderson JE: Nuclear targeting of secretory proteins. Mol Cell Endocrinol 1997, 129:1-5.
44. Lee R, Kermani P, Teng KK, Hempstead BL: Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
45. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R: A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000, 5:197-206.
46. Bush G, diSibio G, Miyamoto A, Denault JB, Leduc R, Weinmaster G: Ligand-induced signaling in the absence of furin processing of Notch1. Dev Biol 2001, 229:494-502.
47. Lam MH, Olsen SL, Rankin WA, Ho PW, Martin TJ, Gillespie MT, Moseley JM: PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. J Cell Physiol 1997, 173:433-446.